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McGovern, Terry McMahon, Susan GallacherUnder European legislation, domoic acid (DA), the main constituent of amnesic shellfish poisoning, is monitored to protect the
shellfish consumer. To ensure comparability amongst analytical data, it was deemed necessary to undertake performance
assessments of the methods conducted by monitoring laboratories of the United Kingdom and Ireland.
In phase I of a two-phase inter-comparison, three laboratories used high-performance liquid chromatography and ultraviolet
detection (HPLC-UV). Concentration data for a DA standard solution, a crude extract of whole scallops and a scallop-homog-
enate fell within internationally accepted limits, demonstrating good agreement for these matrices. Between-laboratory analyses
of a scallop gonad showed a higher variation (>16%).
In phase II, a second gonad homogenate containing DA one order of magnitude higher in concentration gave results acceptable
to internationally set criteria.
The efficiency of the strong anion-exchange cartridges used in sample-extract clean-up should be monitored as part of a laboratory
quality control system.
From a recovery study, it is suggested that recovery correction should also be applied.
Therewas no difference in the quantitationofDA in standard solutions or shellfishusing either LC-UVor LCwithmass spectrometric
(MS) detection, and between-laboratory MS data for a gonad homogenate were also equivalent.
Variations of the published method practised by the monitoring laboratories were found not to compromise results, thus
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D, UK Amnesic shellfish poisoning (ASP) toxins
are produced by microalgae (e.g., Pseudo-
nitzschia spp.) and can accumulate in
shellfish. Consumption of toxic shellfish
may cause a number of effects in humans,
including vomiting, diarrhea and perma-
nent short-term memory loss [1].
European Union (EU) legislation [2] was
amended in 1997 [3], and adopted in the
United Kingdom (UK) in 1998, to include
domoic acid (DA), the main constituent of
ASP toxins, in the suite of biotoxins to be
determined in the regulatory monitoring
of shellfish. The amendment requires
shellfish to contain less than 20 mg/kg of
DA as analyzed by high-performance
liquid chromatography (HPLC) with
ultraviolet (UV) detection; however, no
specific procedure has been officially vali-
dated or recommended by the EU.
The International Scientific Community has proposed
two methods [4,5]. The suitability of these methods is
being investigated by the European Committee on Nor-
malization (CEN) and by a EU working group. Irish and
UK laboratories involved in the regulatory monitoring of
shellfish poisons have since adopted the procedure of
Quilliam et al. [4]. A performance assessment was
deemed necessary to ensure comparability amongst the
monitoring laboratories involved in the routine analyses
of ASP, so inter-laboratory comparisons were under-
taken involving four laboratories whereby concentration
data was reviewed on the basis of applied methodologies.
For the purposes of this inter-comparison study
reported here, three biotoxin-monitoring laboratories
(LAB-1, LAB-2 and LAB-3) were included along with
LAB-4, which participated to develop LC with mass
spectrometric (LC-MS) method of analysis. The study
consisted of two phases. Thus, this article describes
results of an inter-laboratory comparison study, as per-
formed by the four laboratories, of the HPLC-UV and
LC-MS methods used for the detection and quantification
of DA in standard solutions and in real shellfish samples
naturally incurred with DA.2. Inter-laboratory performance studies
External assessments of the quality of the results gener-
ated by individual laboratories and in the form of inter-
laboratory comparisons satisfy the requirement to
demonstrate comparability of analytical data. By
centrally distributing samples, assessments of perfor-
mance in the inter-laboratory studies were made possi-
ble, and the participation in such comparisons proved
necessary in method development and refinement, as
well as validation.
2.1. Sample management
LAB-1 prepared and distributed all of the standard
solutions, scallop-tissue homogenates, and crude
extracts used in both phases of this study. A certified
reference material [CRM, MUS1-B; National Research
Council (NRC) Canada)] containing DA was also exam-
ined in phase II. To assess the stability of the samples
over the study periods, the DA contents in aliquots ofTable 1. Maximum allowable error (MAE) values for different sample mat
Sample matrix MAE (%) Definit
data ba
Standards and crude extract 3.13 6.25
Crude extract processed through SAX clean up 4.7 9.38
Tissue homogenatesa 6.25 12.5
See text for explanation of MAEs.
aProcessing steps including extraction and clean up by SAX.standard solutions, extracts and homogenates were also
determined by LAB-1 prior to sample dispatch, and
following receipt of the results from each of the partici-
pants.
2.2. Statistical analysis and criteria
A comparison of concentration data sets generated by
HPLC-UV and LC-MS were evaluated statistically to
examine if they were significantly different from each
other. This was carried out using a t-test or a one-way
ANOVA on ranks according to Kruskal–Wallis. Statisti-
cal analysis of the data was also conducted in accor-
dance with ‘‘Quality Assurance of Information for
Marine Environmental Monitoring’’ (QUASIMEME)
[6,7], an international proficiency-testing scheme. The
scheme assesses the proficiency of participating labora-
tories by comparing their results with assigned target
values. For each analysis, a ‘‘maximum allowable error’’
(MAE) [8], is defined as the sum of proportional and
constant errors. Data are then assessed as ‘‘satisfactory’’,
‘‘questionable’’ or ‘‘unsatisfactory’’ according to the
degree to which they deviate from the assigned or target
value. For instance, at a MAE value of 12.5%, data
within 25% of the assigned value would be assessed as
‘‘satisfactory’’. Target values were established as either
the nominal values for standard solutions or the mean of
the participants results for DA content in extracts and
tissues.
The statistical model used in this study was based on
the QUASIMEME model using proportional errors and
did not include any allowance for constant errors. The
proportional errors in QUASIMEME inter-comparison
exercises are generally between 6% and 12.5%. Since
there are no agreed international parameters set for the
quality of amnesic shellfish poison (ASP) analyses and,
due to the potential implications to public health of DA
as a food contaminant, the MAEs set in this study were
stricter than those utilized by QUASIMEME. Values also
varied depending on the number of sample-processing
steps used by the participants during extract prepara-
tion. Table 1 details the MAE values assigned for each
sample type analyzed in phases I and II of the inter-
laboratory exercises.rices analyzed in the inter-comparison exercises
ion of satisfactory
sed on assigned value (%)
Number of processing steps for
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.3. Phase I
3.1. Preparation of standard solutions, crude scallop
extracts and homogenates
Standard solutions containing DA were prepared by
weight and by dilution of the certified reference standard
(DACS-1C; NRC, Canada) in 10% aqueous acetonitrile.
Aliquots (0.5 mL) were then transferred to 2 mL amber
ampoules and sealed under nitrogen. The nominal DA
concentration was 2 lg/mL, which the participants did
not know. Ampoules were stored at 2–8C. Crude
extracts were prepared from homogenized scallops
obtained from the Scottish West Coast in 1999. These
methanol/water extracts were filtered with 0.45-lm
syringe filters and combined, and aliquots (0.8 mL) were
then transferred to amber ampoules, sealed under
nitrogen, and stored at 2–8C. Both whole-flesh samples
(including all of the scallop tissue) and gonads were
isolated from the shells, homogenized and stored at
20C. A sub-sample of gonad and whole animal was
thawed thoroughly, autoclaved for 20 min (120C), and
then homogenized for 15 min using an Ultra Turrax.
Aliquots of each homogenate were transferred to 7-mL
bijous, and stored at 20C on the same day.
The three participants (LAB-1, LAB-2 and LAB-3)
manipulated and analyzed standard solutions, shellfish
extracts and homogenates according to Quilliam et al.
[4] with numerous variations; these are summarized in
Tables 2 and 3. All participants in both phases of the
study used dilutions of the certified reference standard of
DA as calibration standards.T
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.3.2. Investigations of sample stability and homogeneity
For both phases I and II, LAB-1 analyzed all samples at
the start (data represented as LAB-1-1) and at the con-
clusion (LAB-1-2) of each exercise. The concentration
data derived from the analyses of the DA standard
solutions, crude and cleaned-up scallop extracts and the
whole-scallop-homogenate were within the MAE (Figs. 1
and 2).
However, and with reference to Fig. 2(b), mean con-
centration data for the scallop gonad fell outside the
MAE value (see LAB-1-1).
In phase II, and for the analyses of the gonad sample,
there was no significant difference in the DA content at
the start (LAB-1-1) and end (LAB-1-2) of the trial (Figs.
4(a) and (b)). This suggests that the distributed samples
were stable over the inter-comparison period, and any
differences observed in the data can be interpreted as
between-laboratory differences.
Homogeneity of the scallop gonads and whole-flesh
samples was determined following their preparation and
prior to the commencement of phase I. The DA plus its
epimer, epi-DA, content of the sub-samples (n = 6) for
each sample type was determined by HPLC-UV.
Table 3. HPLC details for the analysis of DA, as carried out by each participating laboratory
Laboratory
(detection system
Mobile phase HPLC column type Calibration DA
& epi-DA
separationACN (%) Additiveb Guard Analytical Levelsa Range (lg/mL)
LAB-1 phase I
(LC-UV)
10 0.1% TFA 10 · 4.6 mm, 5 lm
Purosphere
250 · 4.6 mm, 5 lm
Spherisorb ODS2
6 0.25–10 Yes
LAB-1 phase II
(LC-UV)
10 0.1% TFA 10 · 4.6 mm, 5 lm
Vydac 201GK54T
250 · 4.6 mm, 5 lm
Vydac 201TP54
6 0.25–10 Yes
LAB-1 phase II
(LC-MS)
9.5 2 mM AF
+ 50 mM FA
10 · 2 mm, 3 lm BDS
Hypersil C8
50 · 2 mm, 3 lm BDS
Hypersil C8
6 0.25–10 Yes
LAB-2 (LC-UV) 15 0.1% TFA 4 · 4 mm, 5 lm
Lichrochart RP18e
250 · 4.0 mm, 5 lm
Lichrosphere RP18e
1 10 Yes
LAB-3 (LC-UV) 10 0.1% TFA None 250 · 4.6 mm, 10 lm
Vydac 201TP104
5 1–50 Yes
LAB-4 phase II
(LC-MS)
12.5 0.1% FA 30 · 4.6 mm, 5 lm
Sphereclone ODS2
250 · 4.6 mm, 5 lm
Sphereclone ODS2
7 0.1–9 Yes
aNumber of DA calibration standards used to calibrate the instrument for each batch of analyses.
bAF, Ammonium formate; FA, Formic acid; TFA, Trifluoroacetic acid.For the gonad sample, a mean concentration and
coefficient of variation (c.v.) of 3.15 mg/kg and
3.2% were found, whereas, for the whole-flesh sample,
144 mg/kg and 11.2% were determined.
Considering the levels of DA contamination associated
with each sample type and their associated percentage
c.v.s, it was concluded that both samples were homo-
geneous and fit for the purpose of this study.
3.3. Sample extraction and analysis by HPLC-UV
Samples were analyzed within 10 days of receipt by the
participants. Using strong anion-exchange (SAX) solid
phase extraction cartridges, each participant also
performed a clean-up stage on the crude-scallop extract
and on their prepared extracts of the whole-scallop and
gonad samples. Thus, for the crude-scallop extract, the
same sample was analyzed before and after SAX clean
up.
With reference to Table 1, the tissue homogenates
were thawed, and 4-g aliquots were weighed into
centrifuge tubes. Following the addition of 16 mL of
methanol:water (1:1 volume:volume; v:v), extraction
was carried out by blending and centrifugation. An
aliquot of the supernatant was transferred to a condi-
tioned SAX cartridge and eluted with either citric or
formic acid buffer following a 10% aqueous:acetonitrile
(v:v) wash. The eluent was then vortex mixed and
analyzed by HPLC-UV.
3.4. Assessment of the effect of elution volume on DA
recovery using the DA CRM
To observe potential losses during the sample-extract
clean-up stage, LAB-1 also assessed the elution of DA
from the SAX cartridge (QMA SAX, Waters Ltd.), as
proposed by Quilliam et al. [4] The elution profile wasdetermined by collecting 0.3-mL fractions over a total
elution volume of 6 mL. Each fraction was then analyzed
for DA by HPLC-UV. This was carried out in triplicate.
The DA concentrations obtained in each fraction were
then plotted against the cumulative elution volume.4. Phase II
All four participants were involved in phase II, and both
LAB-1 and LAB-4 deployed LC-MS techniques. Phase II
involved the analysis of three DA standards (5, 2 and
1 lg/mL), a scallop-gonad homogenate, and a CRM
(MUS1-B). The extraction methodology and HPLC
conditions are summarized in Tables 2 and 3.
LAB-4 applied a different sample-extraction procedure,
which involved vortex mixing (see Table 2) for 2 min,
followed by centrifugation. The volume of the extracting
solvents also differed from the other laboratories in that a
larger volume (20 mL) was used, and the ratio of
methanol-to-water was 2:1 as opposed to 1:1. Although
sample clean-up was the same as the other participating
laboratories in terms of using a SAX sorbent, the total
volume of the crude extract that was cleaned up was
only 3 mL. Elution of DA from the SAX cartridge also
differed, and incorporated 88% acetonitrile with 2%
formic acid as opposed to a citric acid buffer solution.
4.1. Analysis by LC-MS
The LC-MS used by LAB-1 was an API 150ex mass
spectrometer (PE Biosystems) equipped with a Turbo-
Ionspray source and coupled to an Agilent 1100 series
LC, with quaternary pump, degasser, autosampler and
column thermostat compartment (held at 20C). The LC
column, guard and mobile phase used are described in
DA standard (nominal value 2 µg/mL)
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Figure 1. Phase I of the study: analysis of (a) standard DA solution, (b) crude extracts, and (c) crude extracts after SAX clean up.
Error bars represent the standard deviation of the mean.Table 2. All solvents were HPLC grade, and all reagents
were of an analytical grade. Nitrogen was used as the
curtain gas (12 L/min), the spray gas (9 L/min), and the
heater gas (400C; 7 L/min). The ion-spray voltage was
set at 5 kV, the orifice and ring voltage were 10 and
160 V, respectively. Quantification was carried out using
the protonated [M + H]+ ion of DA at m/z 312.
For LAB-4, a single quadrupole mass spectrometer
(Platform II; Micromass), interfaced with an electrospray
ionization source and coupled to an HP1050 HPLC
(Agilent) was used. The cone and capillary voltages were
30 V and 3.6 kV, and the source temperature was
maintained at 160C.
Details of the mobile-phase composition (HPLC
grade) and the LC column are given in Table 2.
External quantification was carried out, and selectedion monitoring of the [M + H]+ ion at m/z 312.4 was
performed.5. Results of the inter-comparison exercises
Concentration data and percentage c.v.s are detailed in
Tables 4 and 5. Mean DA data are presented as scatter
plots, and the error bars represent one standard devia-
tion of the mean (Figs. 1–4).
5.1. Phase I – participant performances
The concentration data obtained by each participant fell
within the MAE of 12.5% for the DA standard (Fig. 1(a)),
the crude extracts of scallop (before and after SAX
clean up; Figs. 1(b) and (c)), and the whole-scallop
(a) Whole scallop
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Mean +12.5 %
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Figure 2. Phase I of study: analysis of (a) whole-scallop-tissue homogenate, and (b) scallop-gonad-tissue homogenate. Error bars represent the
standard deviation of the mean.
Table 4. Concentrations of DA and percentage coefficients of variation (c.v., in parenthesis) for the standard solutions, and crude and cleaned-up
whole-scallop extracts (lg/mL), and the whole and gonad homogenate matrices (mg/kg) analyzed during phase I of the inter-comparison study
using LC-UV detection
Laboratory DA concentration and (% c.v.)
Standard solution Crude extract Cleaned-up extract Whole-scallop extract Scallop gonad
LAB-1-1 2.1 (2.0) 20.4 (0.52) 15.7 (8.9) 123 (11.2) 2.72 (2.6)
LAB-2 1.9 (3.1) 20.7 (1.93) 17.5 (11.1) 115 (1.8) 1.99 (2.0)
LAB-3 1.98 (0.3) 20.1 (0.89) 16.8 (0.6) 128 (4.9) 1.93 (15.2)
LAB-1-2 1.96 (4.8) 20.6 (0.51) 16.6 (3.5) 128 (2.6) 2.46 (8.1)
Mean conc. 1.99 20.5 16.6 124 2.28
Mean c.v. (%) (4.2) (1.3) (4.4) (5.0) (16.7)homogenate (Fig. 2(a)). Excluding the DA-concentration
data derived from the analysis of the scallop gonad
sample, over 80% of the intra- and inter-laboratory c.v.s
were <6% (Table 4). For the determination of DA in
these particular matrices, the performance of the labo-
ratories was deemed satisfactory.
For the analysis of the gonad homogenate, an
overall mean c.v. of 16.7% for the inter-laboratory
study was found (Table 4). The mean concentration
data from each participant were in the range1.93–2.72 mg/kg. However, with the exception of
concentration data acquired at the conclusion of
phase I, all of the c.v. data fell outside the MAE value
of 12.5% (Fig. 2(b)), and the performance of the par-
ticipants in analyzing this sample was deemed unsat-
isfactory.
A possible explanation of these results is that the
participants were attempting to quantify DA at concen-
trations close to their lower limits of determination. Also,
at the lower concentration, adverse effects of using
Table 5. Observed mean DA concentrations and percentage coefficients of variation (c.v.) for standard solutions, and the scallop-gonad
homogenate analyzed during phase II of the trial
Laboratory Nominal DA concentration (lg/mL)
5 2 1 DA + epi-DA in
gonad [mg/kg]
DA + epi-DA in
gonad [mg/kg],
corrected*Observed DA concentration (lg/mL)
Mean c.v. (%) Mean c.v. (%) Mean c.v. (%) Mean c.v. (%) Mean c.v. (%)
LAB-1-1 5.02 1.53 1.98 1.14 0.98 1.83 19.6 5.87 19.9 5.88
LAB-2 5.15 0.64 2.08 1.95 1.02 2.98 19.2 0.89 21.3 0.85
LAB-3 5.10 0.51 2.17 0.53 1.19 0.59 17.0 5.12 19.3 5.18
LAB-4 (MS) 4.90 0.36 1.84 0.82 0.92 0.91 18.5 7.35 23.4 7.35
LAB-1 (MS) 5.03 1.72 2.01 0.92 0.98 0.96 19.4 8.30 19.7 8.17
LAB-1-2 N/A N/A N/A N/A N/A N/A 20.7 8.84 21.0 8.86
Overall 5.04 1.9 2.01 6.0 1.02 10.0 19.1 6.5 20.8 7.2
N/A, Not analyzed.
*Corrected for recovery of DA as determined for the Certified Reference Material MUS-1B (NRC, Canada).single-point calibration compared to multi-level calibra-
tion curves may have a negative effect on accurate
quantification. However, it should be noted where multi-
level calibration solutions were used (e.g., by LAB-3),
similar concentration data was obtained where a single
point curve was applied (e.g., by LAB-2).
These findings suggest that, if DA concentrations of
2 mg/kg in gonad samples are to be routinely quan-
tified in an ASP monitoring programme, further research
is required to optimize the methodology, unless a higher
MAE value (i.e. >25%) is agreed upon. The recent
introduction of a trigger level of 4.6 mg/kg in the
monitoring of ASP in scallops [9] also highlights the
need for proficiency testing at an international level
to demonstrate the performance of official testing
laboratories.
5.2. Assessment of the effect of elution volume on DA
recovery using DA CRM
In phase I, a 19% reduction in the overall mean DA
concentration obtained from all participants was
observed after SAX clean-up of the whole-scallop crude
extract (Table 4), and this led to an investigation of
the recovery efficiency of the clean-up stage. The
elution profile for the recovery of DA in an extract of
the MUS-1B CRM and using a SAX-cartridge is shown
in Fig. 5. Although a large percentage of DA was
eluted within the first 2 mL of elution, a significant
percentage remained as a tailing peak. Analysis per-
formed with laboratories using 2- or 3-mL elution
volumes resulted in DA recovery from the CRM of
79.0–90.4%, whereas the use of 5 mL resulted in
98.4% recovery (Table 6). The participants also used
different brands of SAX cartridges, as detailed in
Table 2. It is possible that the cartridge sorbent could
be a cause of the loss of DA during the extract clean-
up stage. This loss can be addressed by decreasing thecrude extract loading volume, and by increasing the
elution volume. A previous report [4] demonstrates a
93% recovery using a 2-mL eluent volume compared
to the 79.0–90.4% found with the same volume in the
study reported here. Differences in recovery efficiencies
using SAX sorbents can occur, and it is recommended
that batch-to-batch differences of the same brand
should be checked routinely to ensure continuous
quality of analysis.5.3. Phase II – participant performances
The quantitation of DA in the standard solutions
demonstrated that the overall mean concentrations for
the three DA standard solutions were <2% different
from the respective nominal values (Table 5). The c.v.s
for within-laboratory analysis were less than 3% in all
cases, although the inter-laboratory variations were in
the range 1.9–10%, and the percentage c.v. values
increased as the DA-standard concentration decreased
(Table 5).
For the 5-lg/mL DA standard solution, all of the
participant results fell within the 12.5% MAE value
(Fig. 3) and were deemed satisfactory.
However, differences were apparent between concen-
tration data generated for the lower standards (2 and
1 lg/mL), and by the participants using UV alone or
both UV and MS detectors. Where these data fell outside
the MAE value, this suggests problems existed with the
preparation of the DA calibration standards at the time
of the study.
All regulatory laboratories failed to meet the 25%
MAE value for the detection of DA in the gonad
homogenate containing a mean value of 2.28 mg/kg of
DA.
However, all participants achieved satisfactory results
in phase II on analyzing a gonad homogenate contain-
DA standard (nominal value 5 µg/mL)
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Figure 3. Phase II of study: analysis of three DA standard solutions containing concentrations of 5, 2 and 1 lg(DA)/mL, respectively.ing a level of DA one order of magnitude higher in
concentration.
Due to the slightly low DA recoveries obtained from
the CRM (Table 6), the results for the gonad homogenate
analyzed in phase II were plotted both as the sum of DA
and its epimer, epi-DA, concentration before and after
recovery correction was applied (Figs. 4(a) and (b),
respectively). The average concentration of the gonad
homogenate raw data from all participants was
19.1 mg/kg, while the average result for the recovery-
corrected data was 20.8 mg/kg. This represents 8%
negative bias for the uncorrected average between
laboratories.
The c.v.s for between laboratories were 6.5% for data
uncorrected for recovery and 7.2% for recovery-corrected data (Table 5), which were considerably lower
than that obtained between participants for gonad
homogenate in phase I (16.7%; Table 4).
A comparison between LC-UV and LC-MS concentra-
tion data of the scallop gonad showed no significant
difference (Fig. 4).
The study also compared data generated by two
LC-MS techniques [LAB-1(MS) and LAB-4] with con-
centrations obtained by LC-UV detection. The LC-MS
method used by LAB-1, which is an adaptation of the
method described by Hess et al. [10], gave similar results
to the HPLC-UV data for DA standards and gonad
homogenate, reinforcing the finding by Hess et al. [10]
that the techniques can be equivalent. The fact that the
results obtained by two different LC-MS methods were
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Figure 4. Phase II of study: analysis of a scallop-gonad homogenate showing (a) raw data, and (b) recovery corrected data.
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Figure 5. Elution profile of a DA standard solution using a Waters QMA SAX cartridge.
Table 6. The percentage recovery of DA from the CRM (MUS1-B) in relation to the elution volumes applied during clean up
Laboratory DA recovered (%) Elution volume (mL)
LAB-1 (phase I) 89.4 2
LAB-1 (phase II) 98.4 5
LAB-2 90.4 2
LAB-3 87.8 2
LAB-4 79.0 3
similar for the gonad homogenate but differed for the DA
standards again points towards possible inaccuracies in
the preparation of calibration standards.6. Summary
It was apparent that there was a need for laboratories
involved with the regulatory monitoring of DA in shell-
fish to demonstrate comparability of concentration data,
since each laboratory had adopted a single published
method although there were variations in its deploy-
ment. A critical review of the evidence emerging from
the inter-comparisons enabled suggestions to be made to
improve the confidence of the data. This study was
limited to four laboratories, although there was an
obvious requirement to extend such exercises to other
service laboratories responsible for monitoring ASP
toxins in commercial shellfish.
Since this study, inter-comparisons have been initiated
under the auspices of the QUASIMEME programme, and
have embraced a larger participant base. It is expected
that this programme will continue to evolve, providing
laboratories with opportunities to assess and refine their
methodologies in a manner similar to that reported here.
Simultaneously and on a wider scale, it is expected that a
trend of improved analytical data will become evident
amongst monitoring laboratories responsible for safe-guarding the health of shellfish consumer from toxins,
such as domoic acid.Acknowledgements
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